Literature DB >> 22530078

A decade in gastric cancer curative surgery: Evidence of progress (1999-2009).

Stefano Rausei1, Gianlorenzo Dionigi, Francesca Rovera, Luigi Boni, Caterina Valerii, Luisa Giavarini, Francesco Frattini, Renzo Dionigi.   

Abstract

To investigate the progress in evidence-based surgical treatment of non-metastatic gastric cancer, we reviewed the last ten years' literature. The data used in this review were identified by searches made on MEDLINE, Current Contents, PubMed, and other references taken from relevant original articles (on prospective and retrospective studies) concerning gastric cancer surgery. Only papers published in English between January 1999 and December 2009 were selected. Data from ongoing studies were obtained in December 2009, from the trials registry of the United States National Institutes of Health (http://www.clinicaltrial.gov). The citations list was presented according to evidence based relevance (i.e., randomized controlled trials, prospective studies, retrospective series). In the last ten years, many challenges have been faced relating to the extension of gastric resection and nodal dissection as well as surgical timing, but we found only limited evidence, regardless of latitude of study. The ongoing phase-III trials may provide answers that will be valid for the coming decades, and which may bring definitive answers for the currently unresolved questions.

Entities:  

Keywords:  D2 lymphadenectomy; Endoscopic treatment; Evidence-based surgery; Gastric cancer; Laparoscopic gastrectomy; Neoadjuvant therapy

Year:  2012        PMID: 22530078      PMCID: PMC3332221          DOI: 10.4240/wjgs.v4.i3.45

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  107 in total

1.  Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer.

Authors:  H Hayashi; T Ochiai; H Shimada; Y Gunji
Journal:  Surg Endosc       Date:  2005-07-28       Impact factor: 4.584

2.  A learning curve for endoscopic submucosal dissection of gastric epithelial neoplasms.

Authors:  N Kakushima; M Fujishiro; S Kodashima; Y Muraki; A Tateishi; M Omata
Journal:  Endoscopy       Date:  2006-10       Impact factor: 10.093

3.  Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).

Authors:  I Songun; H J Keizer; J Hermans; P Klementschitsch; J E de Vries; J A Wils; J van der Bijl; J H van Krieken; C J van de Velde
Journal:  Eur J Cancer       Date:  1999-04       Impact factor: 9.162

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

Review 5.  Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.

Authors:  Henk H Hartgrink; Cornelis J H van de Velde
Journal:  J Surg Oncol       Date:  2005-06-01       Impact factor: 3.454

6.  A European case series of endoscopic submucosal dissection for gastric superficial lesions.

Authors:  Mario Dinis-Ribeiro; Pedro Pimentel-Nunes; Mariana Afonso; Natalia Costa; Carlos Lopes; Luis Moreira-Dias
Journal:  Gastrointest Endosc       Date:  2009-02       Impact factor: 9.427

7.  Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer.

Authors:  E Orsenigo; V Tomajer; S Di Palo; L Albarello; C Doglioni; E Masci; E Viale; C Staudacher
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

8.  Totally laparoscopic total and subtotal gastrectomy with extended lymph node dissection for early and advanced gastric cancer: early and long-term results of a 100-patient series.

Authors:  Cristiano G S Huscher; Andrea Mingoli; Giovanna Sgarzini; Gioia Brachini; Barbara Binda; Massimiliano Di Paola; Cecilia Ponzano
Journal:  Am J Surg       Date:  2007-12       Impact factor: 2.565

9.  Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.

Authors:  P Edwards; G R J C Blackshaw; W G Lewis; J D Barry; M C Allison; D R B Jones
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  5 in total

Review 1.  Sentinel node navigation surgery in gastric cancer: Current status.

Authors:  Dimitrios Symeonidis; George Koukoulis; Konstantinos Tepetes
Journal:  World J Gastrointest Surg       Date:  2014-06-27

2.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  The Use of Indocyanine Green (ICG) and Near-Infrared (NIR) Fluorescence-Guided Imaging in Gastric Cancer Surgery: A Narrative Review.

Authors:  Francesco Belia; Alberto Biondi; Annamaria Agnes; Pietro Santocchi; Antonio Laurino; Laura Lorenzon; Roberto Pezzuto; Flavio Tirelli; Lorenzo Ferri; Domenico D'Ugo; Roberto Persiani
Journal:  Front Surg       Date:  2022-06-28

4.  Predicting the probability of mortality of gastric cancer patients using decision tree.

Authors:  F Mohammadzadeh; H Noorkojuri; M A Pourhoseingholi; S Saadat; A R Baghestani
Journal:  Ir J Med Sci       Date:  2014-03-14       Impact factor: 1.568

Review 5.  Techniques and Current Role of Sentinel Lymph Node (SLN) Concept in Gastric Cancer Surgery.

Authors:  Dimitrios Symeonidis; Konstantinos Tepetes
Journal:  Front Surg       Date:  2019-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.